Advertisement

Topics

Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression

19:00 EST 8 Nov 2017 | BioSpace

The positive results support the company's planned regulatory submissions.

Original Article: Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression

NEXT ARTICLE

More From BioPortfolio on "Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression"

Advertisement
Quick Search
Advertisement
Advertisement